← back to search

Chun‐Hao Huang

National Cheng Kung University · TW
Area of research
Molecular Biology · Condensed Matter Physics
Research interest
Research interests include Protein Degradation and Inhibitors, Physics of Superconductivity and Magnetism, Epigenetics and DNA Methylation, and Advanced biosensing and bioanalysis techniques.
h-index
27
citations
5,454
works
152
NIH funding
primary concept
Biology
email

Recent publications

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
eLife 2023cited by 20position: middledoi
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets
Proceedings of the National Academy of Sciences 2022cited by 14position: middledoi
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Cancer Cell 2020cited by 159position: middledoi
Leukemia Cell of Origin Influences Apoptotic Priming and Sensitivity to LSD1 Inhibition
Cancer Discovery 2020cited by 43position: middledoi
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Cell 2018cited by 449position: middledoi
The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma
Cancer Cell 2018cited by 159position: middledoi
A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response
Cell 2018cited by 124position: middledoi
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
Trends in cancer 2018cited by 122position: firstdoi
TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation
Cell Death and Disease 2018cited by 56position: middledoi
<i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer
Science 2017cited by 1,038position: middledoi
Prediction of potent shRNAs with a sequential classification algorithm
Nature Biotechnology 2017cited by 202position: middledoi
Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging
Theranostics 2017cited by 62position: middledoi
Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles
ACS Nano 2016cited by 172position: middledoi
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Cell 2014cited by 224position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Scott W. Lowe · Memorial Sloan Kettering Cancer Center10 papers (2016–2023)Darjus F. Tschaharganeh · Heidelberg University7 papers (2014–2023)Ana Banito · German Cancer Research Center4 papers (2014–2023)Chi-Chao Chen · Howard Hughes Medical Institute4 papers (2017–2023)Lars Zender · Deutsche Forschungsgemeinschaft3 papers (2014–2018)Yu-Jui Ho · Research Center for Environmental Changes, Academia Sinica3 papers (2018–2023)John P. Morris · UNC Lineberger Comprehensive Cancer Center3 papers (2018–2023)Elisa de Stanchina · European Molecular Biology Laboratory3 papers (2017–2022)Sha Tian · Hospital for Special Surgery2 papers (2022–2023)Wen Xue · Tianjin University of Science and Technology2 papers (2014–2018)Chun‐Wei Chen · Toyota Motor Corporation (Switzerland)2 papers (2018–2023)Richard P. Koche · New York Proton Center2 papers (2018–2023)Moritz F. Kircher · Memorial Sloan Kettering Cancer Center2 papers (2016–2017)Scott A. Armstrong · Harvard University2 papers (2018–2023)Edward R. Kastenhuber · Weill Cornell Medicine2 papers (2014–2018)Lukas E. Dow · Cornell University2 papers (2014–2022) · 1 papers (2018–2018)Grigori Enikolopov · Johns Hopkins Medicine1 papers (2014–2014)Nikolaus Schultz · Cancer Clinic1 papers (2018–2018)Jesper B. Andersen · University of Copenhagen1 papers (2014–2014)